Developed and executed Clever/Covert's federal advocacy strategy, positioning its proprietary opioid prevention platform that utilizies predictive analytics and clinical decision support before Congress and key Executive Branch agencies, including the Department of Veterans Affairs and HHS, to advance pilot programs, policy initiatives, and federal adoption opportunities focused on early risk identification and improved patient outcomes.
2026 · 3rd Quarter (July 1 - Sep 30)
CLEVER BENEFIT VENTURES, LLC
Filed by THE PETRIZZO GROUP, INC..
Open official filingSource-reported fields
Filing overview
- Type
- 3rd Quarter - Report
- Posted
- Oct 15, 2026
- Income
- $45,000.00
- Expenses
- Not reported
- Registrant
- THE PETRIZZO GROUP, INC.
- Filing UUID
- 7d72c5d9-2825-4f69-9dc3-885b21f31186
- Termination date
- Not reported
Literal source text
Lobbying issues and bill citations
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.